Showing 1 - 6 results of 6 for search 'Kwamena E Baidoo', query time: 0.03s Refine Results
  1. 1
    Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial

    Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial by Diane E. Milenic, Kwamena E. Baidoo, Martin W. Brechbiel

    Published 2015-07-01
    Get full text
    Article
  2. 2
    Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.

    Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model. by Kwon Joong Yong, Diane E Milenic, Kwamena E Baidoo, Martin W Brechbiel

    Published 2016-01-01
    Get full text
    Article
  3. 3
    Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab

    Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab by Diane E. Milenic, Kwamena E. Baidoo, Young-Seung Kim, Rachel Barkley, Martin W. Brechbiel

    Published 2017-08-01
    Get full text
    Article
  4. 4
    HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts.

    HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts. by Tapan K Nayak, Kayhan Garmestani, Diane E Milenic, Kwamena E Baidoo, Martin W Brechbiel

    Published 2011-03-01
    Get full text
    Article
  5. 5
    Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial

    Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial by Diane E. Milenic, Alfredo A. Molinolo, María S. Solivella, Eileen Banaga, Julien Torgue, Sarah Besnainou, Martin W. Brechbiel, Kwamena E. Baidoo

    Published 2015-07-01
    Get full text
    Article
  6. 6
    Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma

    Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma by Meghan M. Bell, Nicholas T. Gutsche, A. Paden King, Kwamena E. Baidoo, Olivia J. Kelada, Peter L. Choyke, Freddy E. Escorcia

    Published 2020-12-01
    Get full text
    Article

Search Tools: